BrainStorm Cell Therapeutics of Petah Tikva is recruiting American patients for a Phase 3 clinical study of its NurOwn stem-cell treatment intended to halt progression of amyotrophic lateral sclerosis (ALS). The announcement was made in a patient webinar last week. The NurOwn platform grew out of a technique developed at Tel Aviv University...
Continue Reading >>
PA Doubles Pay-To-Slay Salary of Terrorist Behind Murder of Three Israeli Teens
After reports earlier this week that the Palestinian Authority (PA) stepped up its support for the sickening “pay-to-slay” policy by